Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Allergan plc (AGN.PRA) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Allergan plc AGN.PRA
Board Mod:
Add me as mod
Asst Mods:
Last Post: 03/15/2015 7:35:06 PM
Board Marks: 0
Posts Today: 0
Board Views Today: 1
Allergan plc (OTCMRKTS: AGN.PRA) Stock Message Board
AGN.PRA Company Profile
AGN.PRA Time & Sales
AGN.PRA Recent News
AGN.PRA Filings
AGN.PRA Financials
AGN.PRA Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
Be the first to post on Allergan plc AGN.PRA
Recent Articles
Transforming DeFi: The Rise of Intelligent AI Superagents
Strategic Resources' AGM Delivers Positive Results for Shareholders
TriNet Declares Quarterly Dividend to Enhance Shareholder Value
FMC Corporation Welcomes Anthony DiSilvestro to Board of Directors
MSA Safety to Lead Discussion on Advanced Safety Technology
Iconic Minneapolis Wells Fargo Center Acquired by Top Investors
Carnegie Learning Celebrates Third Recognition on GSV 150 List
Repare Therapeutics Shares Promising Data on New Cancer Treatment
LeddarTech Secures Key Royalty Payment from Texas Instruments
E2open to Release Third Quarter Financial Results Soon
EPR Properties Announces Monthly and Quarterly Dividend Payouts
Arby’s Unveils Thighsman Award with Joe Theismann's Support
JPMorganChase Welcomes Michele G. Buck to Leadership Team
Transforming Skincare: Ourself Unveils Revolutionary Delivery Tech
Transforming IT Roles: Navigating Cybersecurity and Cloud Challenges
ThriveDX Expands University Partnerships in Cybersecurity Training
John Hancock's Fund Transition to Diversified Income Strategy
Leadership Shift at Darling Ingredients Inc. Marks New Era
John Hancock Funds Enhance Shareholder Value through Repurchase Plans
CoolIT Systems Enhances Production to Meet AI Demand
Commercial Metals Company Embraces Sustainability for 2024
Canaan Inc. Strengthens Market Position with New Partnership
Vir Biotechnology's New Breakthroughs in Hepatitis Delta Therapy
Kuehn Law Advocates for Empire Petroleum Corp Investors
Top Early Childhood Curriculum Innovator Earns GSV 150 Distinction
Aurora Innovation Launches Cutting-Edge Lidar Facility
Corcept Reveals Groundbreaking CATALYST Trial Results for Diabetes
Lawrence (Liren) Chen Joins Arrow Electronics Board of Directors
WD-40 Company Strengthens Leadership with New Chairman Appointment
Moshe Gavrielov Joins Cadence's Board of Directors
Boosting EV Infrastructure: EVgo Secures $1.25 Billion Loan
Good Times Restaurants Sees Growth Amid Operational Change
Scorpio Tankers Secures $500 Million Credit Facility to Boost Growth
RH's Third Quarter Performance: Insights and Financial Overview
Wabash Unveils Innovative Features for 2026 DuraPlate Dry Van
McGrath RentCorp Announces New Quarterly Dividend Plans
Costco Wholesale Achieves Record Sales and Income Growth
Barings Corporate Investors Declares Dividends for Shareholders
Tavia Acquisition Corp. Completes Successful IPO with Full Over-Allotment
Arcosa, Inc. Announces Dividend and Share Buyback Plan Update
Cherry Hill Mortgage Investment Corporation Announces Q4 2024 Dividends
DHT Holdings Announces Strategic Sale of DHT Scandinavia
Redwood Trust Boosts Dividend by 5.9% to Enhance Shareholder Value
Portage Biotech's Nasdaq Listing Compliance Journey Ahead
Equity Residential's Quarterly Dividends Announced for Shareholders
Inventiva Announces Voting Outcomes from Recent Shareholder Meeting
AG Growth International Declares Fourth Quarter Dividend for 2024
Zoetis Announces Significant Dividend Increase for 2025
Barings Participation Investors Declares Special Dividend Boost
Editas Medicine's New Direction: Focusing on In Vivo Gene Editing